MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability ...
Q4 2024 Earnings Call Transcript November 2, 2024 Operator: Good day, and welcome to the S&W Seed Fourth Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.
Type 2 diabetes drug Mounjaro and weight-loss drug Zepbound remained the brightest stars in Lilly's lineup. Mounjaro's sales more than doubled year over year to $3.1 billion. Sales for Zepbound, which ...
This compares to previous guidance of ($67.5) million. Adjusted EBITDA is a financial measure that is not prepared in accordance with generally accepted accounting principles in the United States ...